Table 2.

Aids-Defining illnesses diagnosed concomitantly with TB, n = 310, INI-Fiocruz cohort, 2000–2010

Pneumocystis jirovecii pneumonia; n (%)	42 (13.5)
Candidiasis, Esophageal (presumptive diagnosis); n (%)	18 (5.8)
Toxoplasma gondii encephalitis; n (%)	16 (5.2)
Cytomegalovirus disease (colitis, esophagitis, disseminated); n (%)	6 (1.9)
Histoplasmosis, disseminated; n (%)	5 (1.6)
Kaposi’s sarcoma; n (%)	5 (1.6)
Cryptosporidiosis; n (%)	3 (1.0)
Cryptococcal meningoencephalitis; n (%)	3 (1.0)
HIV-1 encephalopathy; n (%)	1 (0.3)
Lymphoma; n (%)	1 (0.3)

Aids-defining illnesses were defined according to the CDC 1993 definition [15]. A concomitant Aids defining illness was considered when it occurred within 30 days before or after TB treatment initiation